08:00 , Feb 22, 2010 |  BC Week In Review  |  Company News

Advitech other news

Advitech will close its office in Quebec City and transfer its business to its Botaneco Specialty Ingredients Inc. subsidiary in Calgary to reduce costs and align sales and marketing efforts. Advitech acquired Botaneco late last...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Company News

Advitech, SemBioSys deal

Advitech completed its previously announced acquisition of SemBioSys' Botaneco Specialty Ingredients Inc. subsidiary for 43.5 million shares of Advitech at C$0.02 per share, or C$870,000 (US$820,758) (see BioCentury, Nov. 23). Advitech Inc. (TSX-V:AVI), Quebec, Quebec...
08:00 , Nov 23, 2009 |  BC Week In Review  |  Company News

Advitech, SemBioSys deal

SemBioSys will divest its 19.4% holding in subsidiary Botaneco Specialty Ingredients Inc. for 43.5 million shares of Advitech at C$0.02 per share, or C$870,000 (US$830,415). Botaneco develops and markets oleosome-based ingredients to the personal care...
07:00 , May 18, 2009 |  BC Week In Review  |  Clinical News

Advitech preclinical data

In a guinea pig model of scar tissue, IM fraction reduced scar tissue formation compared to control (p<0.05), decreased scar area and improved the macroscopic aspect. In a guinea pig model of polyvinyl alcohol sponge...
07:00 , May 21, 2007 |  BC Week In Review  |  Company News

Advitech board of directors update

Advitech Inc. (TSX-V:AVI), Quebec City, Quebec   Business: Autoimmune   Appointed: Colin Bier, member of the investment committee at AgeChem Venture Fund L.P.; and Pierre Labbe, CFO of Medicago Inc.   Retired: Andre Lamothe  ...
07:00 , May 14, 2007 |  BC Week In Review  |  Company News

Advitech board of directors update

Advitech Inc. (TSX:AVI), Quebec City, Quebec   Business: Autoimmune   Appointed: Colin Bier, member of the investment committee for AgeChem Venture Fund L.P.; and Pierre Labbe, CFO of Medicago Inc.  ...
07:00 , Oct 10, 2005 |  BC Week In Review  |  Clinical News

Advitech preclinical data

In 2 in vivo models of acute and chronic inflammatory bowel disease (IBD), XP-828L significantly improved several clinical parameters associated with inflammatory colitis. XP-828L is a protein extract rich in transforming growth factor (TGF) beta...
08:00 , Nov 15, 2004 |  BC Week In Review  |  Company News

Advitech scientific advisory board update

Advitech Inc. , Quebec City, Quebec   Business: Autoimmune   Appointed: Patrice Poubelle, professor of medicine at Universite Laval, as chairman; and Jean-Paul Marty, professor of dermopharma-cology and cosmetology at the Universite de Paris-Sud  ...
08:00 , Nov 15, 2004 |  BC Week In Review  |  Company News

Advitech management update

Advitech Inc. , Quebec City, Quebec   Business: Autoimmune   Transitioning: Yves Pouliet to associate researcher from VP of R&D, while returning to the Universite Laval as a professor  ...
08:00 , Nov 15, 2004 |  BC Week In Review  |  Clinical News

XP-828L update

AVI began a 112-day, double-blind, placebo-controlled, Canadian study in 84 patients. Advitech Inc. (TSE:AVI), Québec, Quebec   Product: XP-828L   Business: Autoimmune   Molecular target: NA   Description: Protein extract rich in Transforming growth factor...